Had the opportunity of speaking to people at marketing of Thermalife and also Biochoice this week.
Sales are progressing well in WA with a concerted focus on improving eastern states sales. A new broker has been employed, predominantly to crack into eastern states, with experience at this end whilst remaining cost effective, imo.
TT still remains a focus with hopes increasing sales will gain exposure as a news story, as in WA and SA, with no cost to the company.
Biochoice have been called in to be trained on the product so they can further understand the benefits of Thermalife and better able to push the product to Pharmacies.A great move, in my eyes.
Advertising is about to hit the airwaves again with the coy focusing on approaching winter season where arthritis suffers traditionally suffer the most.
Looks like plenty happening on the ground to keep Thermalife exposure and sales increasing.
- Forums
- ASX - By Stock
- CAI
- biotechs in resurgence
biotechs in resurgence, page-6
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAI (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAI (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online